Clinical Trial Update: RAAS Inhibitor Drugs in Dialysis Patients [Phase 4]

View source ↗

Summary

An ongoing Phase 4 trial evaluating RAAS inhibitor drugs in dialysis patients with hypertension and end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hypertension

Drugs mentioned

• RAAS inhibitors (Renin-angiotensin-aldosterone system inhibitors)

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Hypertension, End Stage Renal Disease | Phase 4 | Status: UNKNOWN